Corporate Finance Director Mergers & Acquisitions & Disposals

GlaxoSmithKline; London; Hybrid; GBP 80,000 - 150,000; Full time

Job summary

An established industry player is seeking a Corporate Finance Director to lead Mergers & Acquisitions and Disposals. This pivotal role involves guiding financial reporting for major transactions while fostering collaboration across teams. The ideal candidate will bring extensive experience in corporate finance, strong leadership skills, and the ability to navigate complex financial landscapes. Join a forward-thinking company that values diversity and encourages growth, where your contributions will directly impact the organization’s strategic objectives. Embrace the opportunity to thrive in a hybrid work environment, balancing remote and in-office work while making a meaningful difference in the global biopharma landscape.

Benefits

Annual bonus based on company performance

Healthcare and wellbeing programmes

Pension plan membership

Shares and savings programme

Qualifications

• Experienced leader with a degree in Accounting or Finance.
• Qualified member of a recognized finance body like ICAEW, CIMA, or ACCA.

Responsibilities

• Lead a team of managers and coordinate MA&D processes.
• Provide guidance and support to stakeholders globally.

Skills

Leadership

Group Consolidation

Financial Reporting

Technical Reporting Skills

Interpersonal Skills

Problem Solving

Education

Degree in Accounting or Finance

Qualified member of a recognized professional finance body

Tools

BISON (SAP FC)

Job description

Site Name: UK – London – New Oxford Street, UK - London - Brentford
Posted Date: Jan 30 2025

Corporate Finance Director Mergers & Acquisitions & Disposals

The posting period will end on the 13th of February in 2025

Are you an experienced Corporate Finance Director? If you have experience supporting Mergers & Acquisitions and disposals (MA&D) within a Global Organisation and providing Group reporting guidance and support to key stakeholders when accounting and reporting for major transactions, this could be an exciting opportunity for you to explore.

As a Corporate Finance Director, you will be responsible for supporting the delivery of GSK’s objective of growing and diversifying our business through acquisitions, other collaboration agreements and/or divestments to ensure continued focus on our core business. The role is also critical in delivering timely and accurate financial and management information for group internal and external reporting purposes for these types of transactions.

We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.

We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.

Key responsibilities include, but are not limited to the following:

• Lead and develop a team of 4 managers
• Coordinate and facilitate the corporate teams on MA&D processes including chairing regular meetings to discuss live projects
• Work closely with Deal teams and the wider project team on all aspects of the transaction by inputting into legal contracts, undertaking Due Diligence, identifying Transitional Service activities and pricing, understanding deal close mechanism and structures, asset perimeter and closing statement
• Key member of the Integration/Separation project teams, working cross functionally to execute/implement the transaction, establishing the project plan and the operating model based on the deal assumptions
• Derive solutions to support Day 1 for all MA&D transactions across all functions, in particular reporting and systems requirements and financial deliverables to the finance community
• Provide guidance, support and training to key stakeholders globally involved in the transaction, communicating the main features of the deal
• Build strong relationships across the deal and project transaction teams, acquired/divested business contacts, business sponsors, third party consultants, contracting parties and senior finance leaders
• Promote project governance over all MA&D transaction related activities, including adherence and coordinator of Sox controls over the Transaction processes
• Escalating significant issues and risks with project leads/key stakeholders/steering committee

Basic Qualifications:

We are looking for professionals with the required skills to achieve our goals:

• Experienced leader
• Degree in Accounting or Finance or other related degree discipline
• Qualified member of a recognized professional finance body (e.g. ICAEW / CIMA / ACCA).
• Experience of Group Consolidation and Financial Reporting essential
• Excellent technical reporting skills with knowledge of IFRSs (ideally as they apply to GSK).
• Experience working in an environment that is changing and uncertain, whilst prioritizing activities and delivering under pressure
• Ability to build relationships quickly and develop credibility with stakeholders

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

Please note the following skills are not necessary, just preferred, if you do not have them, please still apply:

• Project management skills
• Extensive knowledge of GSK’s financial processes and consolidation systems at the divisional level and at the group level
• Experience of using BISON (SAP FC) / other Group consolidation reporting systems
• Strong communicator with good interpersonal and presentation skills
• Ability to create solutions to problems and challenges
• An enthusiastic team player with a flexible manner

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology).

Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together.